117 related articles for article (PubMed ID: 531528)
1. Antithrombin III in uremia.
Jørgensen KA; Stoffersen E
Scand J Urol Nephrol; 1979; 13(3):299-303. PubMed ID: 531528
[TBL] [Abstract][Full Text] [Related]
2. [Effect of heparin in uremic patients during hemodialysis].
Cullmann W; Glöckner WM; Müller N
Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
[TBL] [Abstract][Full Text] [Related]
3. [Antithrombin III in chronic renal insufficiency].
Bekić-Kaluza S; Macanović M
Med Arh; 1991; 45(1-2):3-8. PubMed ID: 1366314
[TBL] [Abstract][Full Text] [Related]
4. [Antithrombin III and heparinemia in patients on hemodialysis].
Nagami AE; Sesin AM; Nattero GN
Rev Fac Cien Med Univ Nac Cordoba; 1988; 46(1):23-6. PubMed ID: 3273332
[No Abstract] [Full Text] [Related]
5. Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patients.
Pusineri F; Bini A; Mussoni L; Remuzzi G; Donati MB
J Clin Pathol; 1980 Jul; 33(7):631-4. PubMed ID: 6776154
[TBL] [Abstract][Full Text] [Related]
6. Plasma antithrombin III concentration in patients on regular haemodialysis treatment.
Jørgensen M; Eriksen HO; Tranebjaerg L
Nephron; 1985; 40(1):22-4. PubMed ID: 4000333
[TBL] [Abstract][Full Text] [Related]
7. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
Blavy G; Kouame C
Nephrologie; 1994; 15(6):387-9. PubMed ID: 7862227
[TBL] [Abstract][Full Text] [Related]
8. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
[TBL] [Abstract][Full Text] [Related]
9. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
[TBL] [Abstract][Full Text] [Related]
10. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
Ifudu O; Dawood M; Friedman EA
Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
[TBL] [Abstract][Full Text] [Related]
11. Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation.
Ambühl PM; Wüthrich RP; Korte W; Schmid L; Krapf R
Nephrol Dial Transplant; 1997 Nov; 12(11):2355-64. PubMed ID: 9394323
[TBL] [Abstract][Full Text] [Related]
12. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Held H; Enderle C
Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
[TBL] [Abstract][Full Text] [Related]
14. Variations of protein C in uremic hemodialysed patients.
Nguyen P; Toupance O; Chanard J; Potron G
Thromb Res; 1993 Mar; 69(6):509-18. PubMed ID: 8503120
[TBL] [Abstract][Full Text] [Related]
15. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
Kario K; Matsuo T; Yamada T; Matsuo M
Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
[TBL] [Abstract][Full Text] [Related]
16. [Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].
Yoshida K; Saka M; Kaneko Y; Kubota K; Hirao Y; Okajima E; Ishida M; Kihouin K; Motomiya Y
Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1171-7. PubMed ID: 2625740
[TBL] [Abstract][Full Text] [Related]
17. Protein C activity in renal disease.
Sørensen PJ; Knudsen F; Nielsen AH; Dyerberg J
Thromb Res; 1985 May; 38(3):243-9. PubMed ID: 3839607
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin prevents endothelial and platelet damage during dialysis.
Turney JH; Dodd NJ; Williams LC; Weston MJ
Proc Eur Dial Transplant Assoc; 1981; 18():111-6. PubMed ID: 6460240
[No Abstract] [Full Text] [Related]
19. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist.
Ifudu O; Dawood M; Homel P; Friedman EA
Am J Kidney Dis; 1996 Dec; 28(6):841-5. PubMed ID: 8957035
[TBL] [Abstract][Full Text] [Related]
20. Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis.
Vaziri ND; Toohey J; Paule P; Alikhani S; Hung E
Int J Artif Organs; 1984 Nov; 7(6):323-6. PubMed ID: 6526526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
